Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ce |
RCV001531183 | SCV001746187 | likely benign | not provided | 2021-03-01 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002384870 | SCV002674283 | likely benign | Hereditary cancer-predisposing syndrome | 2021-01-07 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Invitae | RCV003514506 | SCV004272159 | likely benign | Retinoblastoma | 2023-10-29 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV003514506 | SCV004831335 | likely benign | Retinoblastoma | 2023-06-28 | criteria provided, single submitter | clinical testing |